Company · CIK 1699382
PMV Pharmaceuticals, Inc.
| CIK | 1699382 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NJ |
| Listed | PMVP (Nasdaq) |
| First annual or quarterly report | 2020-11-13 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-283349 | 2024-11-20 | 2026-09-02 | 4 | |
| 333-260012 | 2021-10-04 | 2023-04-28 | 2 | |
| 333-248627 | 2020-09-04 | 2020-09-25 | 5 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-02 | 424B5Shelf takedown | 333-283349 | 0001193125-26-378780 |
| 2026-08-31 | 424B5Shelf takedown | 333-283349 | 0001193125-26-376860 |
| 2024-11-27 | EFFECTDeclared effective | 333-283349 | 9999999995-24-003606 |
| 2024-11-20 | S-3Shelf registered | 333-283349 | 0001193125-24-262148 |
| 2023-04-28 | EFFECTDeclared effective | 333-260012 | 9999999995-23-001090 |
| 2021-10-04 | S-3ASRShelf registered | 333-260012 | 0001193125-21-290972 |
| 2020-09-25 | 424B4Final prospectus | 333-248627 | 0001193125-20-254551 |
| 2020-09-24 | EFFECTDeclared effective | 333-248627 | 9999999995-20-002572 |
| 2020-09-24 | S-1/AAmendment | 333-248627 | 0001193125-20-252783 |
| 2020-09-21 | S-1/AAmendment | 333-248627 | 0001193125-20-249570 |
| 2020-09-04 | S-1Registration filed | 333-248627 | 0001193125-20-240132 |
| 2020-06-26 | DRSDraft made public | 377-03247 | 0000950123-20-006405 |